Rondo Therapeutics, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Zhifei Commits To Acquiring $2.93bn Of

Red Tree Venture Capital hopes to provide early-stage VC funding to life science start-ups emerging from academic and research institutions on the West Coast – funding that, the firm believes, has bee

Atlas Venture added more fuel to its biotechnology start-up engine with a $450m fund announced on 3 March, which the venture capital firm will invest in new companies developing novel therapeutics and